AR-V7 in metastatic prostate cancer: a strategy beyond redemption
By microdosing, were leveraging the benefitsinsulin regulation, appetite reset, inflammation reductionwithout shocking the system
A new pharmacy analysis found few people taking GLP-1 drugs like Ozempic and Wegovy stay on these medications after a year
Are there any natural alternatives
Shared decision-making between the patient and their care team is indicated to decide whether to start, continue or discontinue GLP-1 therapy in the setting of a new diagnosis of NAION or in certain risk contexts, considering the individual patient characteristics and clinical scenario, the guidance article authors wrote
Body weight and composition may theoretically influence drug distribution, as semaglutide binds extensively to albumin and distributes into tissues